Elmhurst,IL (PRWEB) October 03, 2013
J.A.R. Laboratories (JAR) announced today that it has settled its lawsuit with Teikoku Pharma USA, Inc. (TPU) as well as JAR’s counterclaims. TPU filed suit in March 2012 in the United States District Court for the Eastern District of Illinois, No. 12cv1864, based in Chicago for false advertising. J.A.R. continues to believe its advertising of LidoPatch® has been completely ethical and legal.
LidoPatch® will be the first Over the Counter pain patch that contains lidocaine hcl and menthol for patients with minor pain associated with arthritis, back ache and muscle aches and sprains. Full commercial availability of LidoPatch® is expected within the next couple of months.
About J.A.R. Laboratories, LLC
J.A.R. Laboratories, LLC, a specialty pharmaceutical company, with a unique focus and expertise in Transdermal Drug Delivery, that is driven by the relentless pursuit to develop and make accessible unique products that improve the lives of people suffering from pain.